Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder

Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder

Eiji Harada,1 Osamu Shirakawa,2 Yoichi Satoi,3 Lauren B Marangell,4 Rodrigo Escobar5 1Eli Lilly Japan K.K., Medicines Development Unit Japan, Medical Science, Kobe, 2Department of Neuropsychiatry, Kinki University Faculty of Medicine, Osakasayama, 3Eli Lilly Japan K.K., Medicines Development Unit J...

Full description

Bibliographic Details
Main Authors: Harada E, Shirakawa O, Satoi Y, Marangell LB, Escobar R
Format: Article
Language:English
Published: Dove Medical Press 2016-01-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
antidepressant
dose
duloxetine
major depressive disorder
titration
Online Access:https://www.dovepress.com/treatment-discontinuation-and-tolerability-as-a-function-of-dose-and-t-peer-reviewed-article-NDT

Internet

https://www.dovepress.com/treatment-discontinuation-and-tolerability-as-a-function-of-dose-and-t-peer-reviewed-article-NDT

Similar Items